Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

Expression of the oncogenic transcription factor MYC is disproportionately elevated in triple-negative breast cancer (TNBC) compared to estrogen, progesterone and human epidermal growth factor 2 receptor-positive (RP) breast tumors(1,2). We and others have shown that MYC alters metabolism during tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Camarda, Roman, Zhou, Zhou, Kohnz, Rebecca A., Balakrishnan, Sanjeev, Mahieu, Celine, Anderton, Brittany, Eyob, Henok, Kajimura, Shingo, Tward, Aaron, Krings, Gregor, Nomura, Daniel K., Goga, Andrei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892846/
https://www.ncbi.nlm.nih.gov/pubmed/26950360
http://dx.doi.org/10.1038/nm.4055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892846/
https://www.ncbi.nlm.nih.gov/pubmed/26950360
http://dx.doi.org/10.1038/nm.4055

Ejemplares similares